Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)
Purpose: In patients with platinum-sensitive relapsed (PSR) ovarian cancer, olaparib maintenance monotherapy significantly improves progression-free survival (PFS) versus placebo. However, evidence in the Asian population is lacking. This is the first study to evaluate olaparib efficacy and tolerabi...
Saved in:
Main Authors: | Gao, Qinglei, Zhu, Jianqing, Zhao, Weidong, Huang, Yi, An, Ruifang, Zheng, Hong, Qu, Pengpeng, Wang, Li, Zhou, Qi, Wang, Danbo, Lou, Ge, Wang, Jing, Wang, Ke, Low, John, Kong, Beihua, Abdul Malik, Rozita, Sen, Lim Chun, Yin, Rutie, Xie, Xing, Liu, Jihong, Sun, Wei, Su, Jingya, Zhang, Chunyi, Zang, Rongyu, Ma, Ding |
---|---|
Format: | Article |
Published: |
Amer Assoc Cancer Research
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/42135/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
by: Li, Huayi, et al.
Published: (2024) -
Discovery of ruthenium(ii) metallocompound and olaparib synergy for cancer combination therapy
by: Yusoh, Nur Aininie, et al.
Published: (2023) -
Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia
by: Said, M.A., et al.
Published: (2013) -
Infographic: “Planet Trial: Intravitreal aflibercept monotherapy for Polypoidal Choroidal Vasculopathy (PCV)”
by: Sim, Shaun Sebastian, et al.
Published: (2022) -
Analyzing the role of family support, coping strategies and social support in improving the mental health of students: Evidence from post COVID-19
by: Yang, Chunying, et al.
Published: (2022)